Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 7, Pages 1558
Publisher
MDPI AG
Online
2021-03-29
DOI
10.3390/cancers13071558
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare
- (2021) Xiaotao Zhang et al. CANCER CAUSES & CONTROL
- IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC).
- (2021) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
- (2021) D.J. McGrail et al. ANNALS OF ONCOLOGY
- Immunological role and underlying mechanisms of B7‐H6 in tumorigenesis
- (2020) Yuxuan Hu et al. CLINICA CHIMICA ACTA
- Mechanisms of liver fibrosis and its role in liver cancer
- (2020) Debanjan Dhar et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
- (2020) Joseph C Ahn et al. HEPATOLOGY
- Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
- (2020) Maria Tampaki et al. Cancers
- Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes
- (2020) Asmaa M. Zahran et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hepatocellular Carcinoma Cells Upregulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice
- (2020) David Kung-Chun Chiu et al. GASTROENTEROLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE).
- (2020) Delvys Rodriguez-Abreu et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancer
- (2020) Xiuqin Zhang et al. Annals of Translational Medicine
- O-6 The novel regimen of tremelimumab in combination with durvalumab provides a favorable safety profile and clinical activity for patients with advanced hepatocellular carcinoma
- (2020) R. Kelley et al. ANNALS OF ONCOLOGY
- NKp30 – a prospective target for new cancer immunotherapy strategies
- (2020) Pedro F. Pinheiro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Improving the Efficacy of Liver Cancer Immunotherapy: the Power of Combined Preclinical and Clinical Studies
- (2020) Gen‐Sheng Feng et al. HEPATOLOGY
- Clinicopathological significance of CD47 expression in hepatocellular carcinoma
- (2020) Hyunsung Kim et al. JOURNAL OF CLINICAL PATHOLOGY
- Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis
- (2020) Mengzhou Guo et al. Journal of Translational Medicine
- Profiling the circulating mRNA transcriptome in human liver disease
- (2020) Aejaz Sayeed et al. Oncotarget
- Tim-3 finds its place in the cancer immunotherapy landscape
- (2020) Nandini Acharya et al. Journal for ImmunoTherapy of Cancer
- Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
- (2020) Mina S. Makary et al. Cancers
- CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions
- (2020) Pascal Leclair et al. Animal Cells and Systems
- Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
- (2020) Mengjia Song et al. BRITISH JOURNAL OF CANCER
- TIGIT Can Exert Immunosuppressive Effects on CD8+ T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro
- (2020) Changkun Zhang et al. JOURNAL OF IMMUNOTHERAPY
- CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
- (2020) Rodrigo Catalán et al. Journal of Immunology Research
- Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives
- (2020) Piera Federico et al. Cancers
- Expression of Inhibitory Receptors on T and NK Cells Defines Immunological Phenotypes of HCV Patients with Advanced Liver Fibrosis
- (2020) Chisom Ifeoma Adaeze Okwor et al. iScience
- Dual role of B7‐H6 as a novel prognostic marker in hepatocellular carcinoma
- (2020) Hao Qiu et al. APMIS
- Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
- (2020) Benjamin Ruf et al. Cellular & Molecular Immunology
- The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time’s a Charm
- (2020) Quentin Lecocq et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sinusoidal Endothelial Cell Progenitor Cells Promote Tumour Progression in Patients with Hepatocellular Carcinoma
- (2020) Ya-xing Feng et al. Stem Cells International
- Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3
- (2019) Yi-Ming Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Combined locoregional-immunotherapy for liver cancer
- (2019) Tim F. Greten et al. JOURNAL OF HEPATOLOGY
- Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
- (2019) Daniel Neureiter et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3 Knock-In Mice
- (2019) Elena Burova et al. MOLECULAR CANCER THERAPEUTICS
- Expression of TIGIT/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma
- (2019) Xiangguo Duan et al. Molecular Medicine Reports
- LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
- (2019) T Yau et al. ANNALS OF ONCOLOGY
- PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma
- (2019) Xiaoli Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
- (2019) Jan Best et al. Clinical Gastroenterology and Hepatology
- International trends in hepatocellular carcinoma incidence, 1978–2012
- (2019) Jessica L. Petrick et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes
- (2019) Silvia Mezzalira et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TIGIT as an emerging immune checkpoint
- (2019) H. Harjunpää et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic value of B7-H6 in esophageal squamous cell carcinoma
- (2019) Huan Zhou et al. Scientific Reports
- Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
- (2018) Valerie Chew et al. GUT
- Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma
- (2018) Xiang Jing et al. Journal of Cancer Research and Therapeutics
- Correlation between serum galectin-9 levels and liver fibrosis
- (2018) Koji Fujita et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
- (2018) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- Targets for immunotherapy of liver cancer
- (2018) Tim F. Greten et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
- (2018) Lujun Chen et al. Cancer Cell International
- Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation
- (2018) John B. Kisiel et al. HEPATOLOGY
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Tim-3 expression and its role in hepatocellular carcinoma
- (2018) Feifei Liu et al. Journal of Hematology & Oncology
- Integrative genomic analysis of mouse and human hepatocellular carcinoma
- (2018) Michelle Dow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
- (2017) Guoying Zhou et al. GASTROENTEROLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Effects of microwave ablation on T-cell subsets and cytokines of patients with hepatocellular carcinoma
- (2017) Haiwen Zhang et al. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
- High expression of B7-H6 in human glioma tissues promotes tumor progression
- (2017) Tianwei Jiang et al. Oncotarget
- PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
- (2017) Carmen Stecher et al. Frontiers in Immunology
- Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma
- (2016) FEIFEI WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
- (2016) Ruea-Yea Huang et al. OncoImmunology
- Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages
- (2015) Wenjiang Yan et al. GUT
- Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
- (2015) KOJI FUJITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation
- (2015) Nobuko Serizawa et al. LABORATORY INVESTIGATION
- Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma
- (2015) Jessica Lo et al. LIVER INTERNATIONAL
- Effect of transcatheter arterial chemoembolization on cellular immune function and regulatory T cells in patients with hepatocellular carcinoma
- (2015) JUAN LIAO et al. Molecular Medicine Reports
- Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging—A Systematic Review and Meta-Analysis
- (2015) Yoon Jin Lee et al. RADIOLOGY
- LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
- (2015) Ruea-Yea Huang et al. Oncotarget
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
- (2014) F. Xu et al. CANCER RESEARCH
- Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation
- (2014) Barbara Behm et al. GUT
- The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers
- (2013) P. J. Johnson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma
- (2013) Min Ju Kim et al. CYTOKINE
- Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
- (2013) Chun-Ju Chiang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
- (2012) Eishiro Mizukoshi et al. HEPATOLOGY
- Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients
- (2012) Fu-Jun Li et al. IMMUNOLOGY LETTERS
- Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy
- (2011) R. Waitz et al. CANCER RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes
- (2011) Tetsuya Nakatsura INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-infiltrating NY-ESO-1–specific CD8+T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
- (2010) Junko Matsuzaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased Immunostimulatory Activity Conferred to Antigen-presenting Cells by Exposure to Antigen Extract From Hepatocellular Carcinoma After Radiofrequency Thermal Ablation
- (2009) Alessandro Zerbini et al. JOURNAL OF IMMUNOTHERAPY
- Radiofrequency Ablation Induces Antigen-presenting Cell Infiltration and Amplification of Weak Tumor-induced Immunity
- (2009) Sergio A. Dromi et al. RADIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started